Invivyd Inc

IVVD | $2.365 -4.64% -4.86% 470K

(0.0% 1d) (-22.0% 1m) (108.4% 1y) (0.0% 2d) (0.0% 3d) (-11.7% 7d) (7.6% volume)
Earnings Calendar:
Market Cap: $ 281,958,209
https://adagiotx.com
Sec Filling | Patents | 2021 employees

Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has been optimized using Adimab’s industry-leading antibody engineering capabilities and is designed to provide patients and clinicians with a powerful combination of potency, breadth, durable protection (via half-life extension), manufacturability and affordability. Adagio’s portfolio of SARS-CoV-2 antibodies includes multiple, non-competing broadly neutralizing antibodies with distinct binding epitopes, led by ADG20. Adagio has secured manufacturing capacity for the production of ADG20 with third-party contract manufacturers through the completion of clinical trials and, if approved by regulatory authorities, through initial commercial launch.

optical security

add to watch list Paper trade email alert is off

TeraWulf Inc

WULF | $2.135 8.93% 8.2% 12M

Manufacturing

(0.0% 1d) (-15.9% 1m) (37.1% 1y) (0.0% 2d) (0.0% 3d) (1.0% 7d) (-10.48% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 645,272,363
https://terawulf.com
Sec Filling | Patents | 58 employees

TeraWulf was formed to own and operate fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy.

mining nuclear solar energy

add to watch list Paper trade email alert is off